← All trials
NCT02095873
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2014
- Primary completion
- Feb 1, 2015
- Completion date
- May 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 32
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of WarwickLead sponsor
- University of WarwickOverall official - principal investigator
- University of WarwickReponsible party - principal investigator
- University of WarwickStudy chair
- Technology Strategy Board, United KingdomCollaborator
- UnileverCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.